This issue of Horizon looks at EU research which is holding out the promise of radical new treatments for cancer.
Around 1.8 million Europeans died of cancer last year, making it the second-biggest killer after cardiovascular disease. In November, Horizon looks at powerful new techniques that could improve cancer survival rates.
We look at technology that allows doctors to stay ahead of mutations in tumour cells by adapting treatments in real time, and we examine techniques that can turn a patient’s immune system against cancer.
For our Views section, Professor Martine Piccart, a former president of the European Organisation for Research and Treatment of Cancer, explains what is required to individualise cancer therapy, so that it matches the specific needs of each patient.
Professor Martine Piccart is a past president of the European Organisation for Research and Treatment of Cancer, Chair of the Breast International Group (BIG) and head of medicine at the Jules Bordet cancer hospital in Brussels. She explains that cancer research needs to change so that cancer treatment can become truly personalised.
What are the latest techniques being developed to stop counterfeit drugs at the border? Why do countries still prefer bi- and multilateral agreements over global deals, and how does trade play into financial crises? This February, Horizon uncovers what’s setting the course for global trade.
Detecting diseases, removing CO2 from chemicals and uncovering the composition of the earth’s core: diamonds have many more uses than just decorating our hands. This January, Horizon talks to the researchers who are unearthing new ways of using one of nature’s most treasured materials.
Gravitational waves have been detected on earth for the first time, researchers at the Laser Interferometer Gravitational-wave Observatory (LIGO) in the US and the VIRGO detector in Italy have announced.
The planned European Cancer Information System (ECIS) will allow citizens to compare the quality of cancer care across different Member States.